-
1دورية أكاديمية
المؤلفون: Çağlar Ünal, Tolga Özmen, Çetin Ordu, Kezban Nur Pilanci, Ahmet Serkan İlgün, Erhan Gökmen, Elvina Almuradova, Mustafa Özdoğan, Nilüfer Güler, Cihan Uras, Halil Kara, Orhan Demircan, Selver Işık, Gül Alço, Pınar Saip, Esra Aydın, Tomris Duymaz, Filiz Çelebi, Kanay Yararbaş, Gursel Soybir, Vahit Ozmen
المصدر: Frontiers in Oncology, Vol 13 (2023)
مصطلحات موضوعية: clinicopathologic characteristics, early-stage breast cancer, lymph node-negative, Oncotype DX®, recurrence score, 21 genes, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2023.1151733/fullTest; https://doaj.org/toc/2234-943XTest
-
2دورية أكاديمية
المؤلفون: Ahmet Serkan Ilgun, Dauren Sarsenov, Gul Alco, Alper Ozturk, Filiz Agacayak, Filiz Elbuken, Zeynep Erdogan, Kezban Nur Pilanci, Cetin Ordu, Fatma Aktepe, Gursel Soybir, Vahit Ozmen
المصدر: Acta Clinica Croatica, Vol 61., Iss 1., Pp 30-37 (2022)
مصطلحات موضوعية: Breast cancer, Breast MRI, Breast-conserving surgery, Overall survival, Local failure, Oncologic outcome, Medicine
وصف الملف: electronic resource
العلاقة: https://hrcak.srce.hr/file/405837Test; https://doaj.org/toc/0353-9466Test; https://doaj.org/toc/1333-9451Test
-
3دورية أكاديمية
المؤلفون: Ozgur Tanriverdi, Eyup Murat Yilmaz, Serkan Menekse, Suna Cokmert, Esin Oktay, Kezban Nur Pilanci, Muharrem Kocar, Nilufer Avci, Tulay Akman, Gamze Goksel, Nezih Meydan, Sabri Barutca
المصدر: Journal of Oncological Sciences, Vol 2, Iss 2, Pp 48-52 (2016)
مصطلحات موضوعية: Colorectal cancer, Recurrence, Intra-abdominal lymph node, KRAS, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2452336416300309Test; https://doaj.org/toc/2452-3364Test
-
4دورية أكاديمية
المؤلفون: Çağlar Ünal, Çetin Ordu, Tolga Özmen, Ahmet Serkan İlgun, Filiz Çelebi, Bülent Baysal, Enver Özkurt, Tomris Duymaz, Zeynep Erdoğan İyigün, Sevgi Kurt, Mehmet Alper Öztürk, Kezban Nur Pilancı, Gül Alço, Kanay Yararbaş, Tuba Kayan Tapan, Deniz Can Güven, Gürsel Soybir, Vahit Özmen
المصدر: Current Oncology, Vol 30, Iss 666, Pp 9217-9229 (2023)
مصطلحات موضوعية: anti-mullerian hormone, antral follicle counts, breast cancer, chemotherapy-induced amenorrhea, median ovarian volumes, ovarian reserve, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: https://www.mdpi.com/1718-7729/30/10/666Test; https://doaj.org/toc/1198-0052Test; https://doaj.org/toc/1718-7729Test; https://doaj.org/article/22ea879de88644029998ba26a0023112Test
الإتاحة: https://doi.org/10.3390/curroncol30100666Test
https://doaj.org/article/22ea879de88644029998ba26a0023112Test -
5دورية أكاديمية
المؤلفون: Çağlar Ünal, Tolga Özmen, Çetin Ordu, Cihan Uras, Halil Kara, Erhan Gökmen, Mustafa Özdoğan, Orhan Demircan, Kezban Nur Pilancı, Tomris Duymaz, Vahit Özmen
المصدر: European Journal of Breast Health, Vol 19, Iss 4, Pp 325-330 (2023)
مصطلحات موضوعية: breast cancer, predict tool, oncotype dx recurrence score, tailorx risk categorization, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Medicine
العلاقة: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/assessment-high-risk-breast-cancer-in-older-patien/62276Test; https://doaj.org/toc/2587-0831Test; https://doaj.org/article/6fad4a8683334e6b96868a32066190cdTest
الإتاحة: https://doi.org/10.4274/ejbh.galenos.2023.2023-8-5Test
https://doaj.org/article/6fad4a8683334e6b96868a32066190cdTest -
6
المؤلفون: Pınar Gursoy, Ali Murat Tatli, Dilek Erdem, Erdem Goker, Emir Celik, Nebi Serkan Demirci, Abdullah Sakin, Muhammed Mustafa Atci, Ertuğrul Bayram, Tuğba Akın Telli, Burak Bilgin, Ahmet Bilici, Baran Akangunduz, Sevinç Balli, Ahmet Demirkazik, Fatih Selçukbiricik, Serkan Menekse, Eyyüp Cavdar, Akın Ozturk, Esma Türkmen Bekmez, Serdal Turhal, Sadettin Kilickap, Hasan Çağrı Yildirim, Başak Oyan, Asude Aksoy, Fatma Paksoy Turkoz, Engin Kut, Nuran Katgi, Teoman Sakalar, Murat Akyol, Halil İbrahim Ellez, Atakan Topcu, Atike Pınar Erdoğan, Kezban Nur Pilanci, Engin Hedem, Hacı Arak, Nadiye Akdeniz, Özkan Alan, Burcu Yapar, Deniz Nart, Perran Fulden Yumuk
المساهمون: TOPÇU, Atakan, İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Paksoy Turkoz, Fatma, ABF-9350-2020
المصدر: Journal of Cancer Research and Clinical Oncology. 149:865-875
مصطلحات موضوعية: Tyrosine Kinase Inhibitor, Cancer Research, Growth-Factor Receptor, a Turkish Oncology Group (TOG) study-, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022 [-Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations], Efficacy, General Medicine, Afatinib, NSCLC, 1st-Line Treatment, respiratory tract diseases, Erlotinib, Oncology, Exon 20, Exon 18, Chemotherapy, Open-Label, Multicenter
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6dfec0cbcbdd9f35f252256f8357168Test
https://doi.org/10.1007/s00432-022-03984-5Test -
7دورية أكاديمية
المؤلفون: Çetin Ordu, Kezban Nur Pilancı, Gül Alço, Filiz Elbüken, Ülkühan İner Köksal, Serkan İlgun, Dauren Sarsenov, Ayşe Esra Aydın, Alper Öztürk, Zeynep İyigün Erdoğan, Filiz Ağaçayak, Fatmagül Çubuk, Coşkun Tecimer, Yeşim Eralp, Tomris Duymaz, Fatma Aktepe, Vahit Özmen
المصدر: European Journal of Breast Health, Vol 14, Iss 3, Pp 173-179 (2018)
مصطلحات موضوعية: chemotherapy-induced amenorrhea, molecular subtypes, breast cancer, survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Medicine
العلاقة: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/prognostic-significance-of-adjuvant-chemotherapy-n/42041Test; https://doaj.org/toc/2587-0831Test; https://doaj.org/article/456fbf37ff914d6c9dee1064ff92ea33Test
الإتاحة: https://doi.org/10.5152/ejbh.2018.3808Test
https://doaj.org/article/456fbf37ff914d6c9dee1064ff92ea33Test -
8
المؤلفون: Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
المساهمون: ŞİMŞEK, MELİH
المصدر: Cancer Investigation. 39:473-481
مصطلحات موضوعية: Oncology, Turkey, retrospective study, T-DM1, diarrhea, heart failure, thrombocytopenia, 0302 clinical medicine, aspartate aminotransferase, infusion related reaction, estrogen, genetics, Neoplasm Metastasis, cancer survival, skin and connective tissue diseases, Aged, 80 and over, progression free survival, portal hypertension, clinical trial, General Medicine, nausea, anemia, Metastatic breast cancer, 030220 oncology & carcinogenesis, immunological antineoplastic agent, oral mucositis, musculoskeletal diseases, medicine.medical_specialty, progesterone, Article, multiple cycle treatment, paresthesia, hypomagnesemia, 03 medical and health sciences, turkey (bird), neutropenia, metastasis, Humans, human, acne, cystitis, neoplasms, human epidermal growth factor receptor 2 positive breast cancer, Aged, Retrospective Studies, trastuzumab emtansine, hypophosphatemia, leukopenia, ERBB2 protein, human, thromboembolism, hyperkalemia, medicine.disease, major clinical study, Survival Analysis, drug efficacy, multicenter study, 030104 developmental biology, chemistry, epidermal growth factor receptor 2, fatigue, proteinuria, disease activity, drug tolerability, drug hypersensitivity, 0301 basic medicine, vomiting, Cancer Research, drug safety, hyponatremia, Survival, Receptor, ErbB-2, very elderly, efficacy, hyperuricemia, hypocalcemia, Ado-Trastuzumab Emtansine, Turkey (republic), chemistry.chemical_compound, Antineoplastic Agents, Immunological, brain metastasis, pain, lapatinib, hypernatremia, breast tumor, Middle Aged, visceral metastasis, humanities, trastuzumab, Treatment Outcome, gamma glutamyltransferase, immunohistochemistry, Female, real world experience.-, Cancer investigation, ss.1-22, 2021 [Bahçeci A., Paydaş S., Ak N., Ferhatoğlu F., Saip P. M. , Seydaoğlu G., Bilici M., Şimşek M., Tekin S. B. , Çalikuşu Z., et al., -Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer], bilirubin, alkaline phosphatase, Receptor, Adult, congenital, hereditary, and neonatal diseases and abnormalities, side effect, alanine aminotransferase, overall survival, Breast Neoplasms, spine metastasis, delirium, male, pertuzumab, acute kidney failure, Internal medicine, hypokalemia, medicine, pneumonia, controlled study, fluorescence in situ hybridization, business.industry, liver failure, hypercalcemia, hypertransaminasemia, toxicity, alopecia, hand foot syndrome, human tissue, real-world experience, clinical feature, febrile neutropenia, hypoglycemia, Trastuzumab emtansine, hyperglycemia, business, metabolism
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e995dc25bd5d60e4fc0b04e58d82c9eaTest
https://doi.org/10.1080/07357907.2021.1933011Test -
9دورية أكاديمية
المؤلفون: Mine Özkan, Nazmiye Yıldırım, Rian Dişçi, Ahmet Serkan İlgün, Dauren Sarsenov, Gül Alço, Fatma Aktepe, Nesiba Kalyoncu, Filiz İzci, Derya Selamoğlu, Çetin Ordu, Kezban Nur Pilancı, Zeynep İyigün Erdoğan, Yeşim Eralp, Vahit Özmen
المصدر: European Journal of Breast Health, Vol 13, Iss 4, Pp 206-212 (2017)
مصطلحات موضوعية: breast cancer, coping, psychosocial stress, risk factors, social support, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Medicine
العلاقة: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/roles-of-biopsychosocial-factors-in-the-developmen/42084Test; https://doaj.org/toc/2587-0831Test; https://doaj.org/article/20db94b739464c63bd9cd7664d16ce27Test
الإتاحة: https://doi.org/10.5152/ejbh.2017.3519Test
https://doaj.org/article/20db94b739464c63bd9cd7664d16ce27Test -
10
المؤلفون: Özlem Özdemir, Baha Zengel, Yaşar Yildiz, Basak Oyan Uluç, Devrim Cabuk, Ercan Ozden, Derya Kivrak Salim, Semra Paydas, Atakan Demir, Omer Diker, Kezban Nur Pilanci, Özlem Uysal Sönmez, Sezai Vatansever, Izzet Dogan, Ahmet Gulmez, Burcu Cakar, Pinar Gursoy, Mahmut Emre Yildirim, Murat Ayhan, Nuri Karadurmus, Musa Baris Aykan, Gökcen Tugba Cevik, Teoman Sakalar, Ilhan Hacibekiroglu, Burcu Belen Gülbagci, Murat Dincer, Duygu Bayir Garbioglu, Yasemin Kemal, Erdinc Nayir, Halil Taskaynatan, Mesut Yilmaz, Okan Avci, Murat Sari, Ezgi Coban, Muhammed Mustafa Atci, Selin Aktürk Esen, Tugba Akin Telli, Fatih Karatas, Ali Inal, Hacer Demir, Nurhan Onal Kalkan, Cengiz Yilmaz, Funda Tasli, Ahmet Alacacioglu
مصطلحات موضوعية: Component, Cancer Research, Pathological Complete Response, Receptor, ErbB-2, Breast Neoplasms, Docetaxel, Antibodies, Monoclonal, Humanized, Neosphere, Trial, breast cancer, Her2, Carcinoma In-Situ, pertuzumab, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Chemotherapy, Pharmacology (medical), Multicenter, Pharmacology, Middle Aged, Trastuzumab, Neoadjuvant Therapy, Carcinoma, Intraductal, Noninfiltrating, Oncology, Female, Open-Label, Therapy, pathological response, neoadjuvant chemotherapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::934c684ccacc5bd283fae448009bb29fTest
https://hdl.handle.net/11454/77368Test